The Met Office has shed light on the rare weather phenomenon responsible for whipping up 114mph winds off Ireland's west ...

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ:TMDX). Such ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...

Kavery Nambisan’s new novel, telling a story of religion, caste and gender, shows her at the top of her game ...

TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.

We maintain cautious stance on TransMedics investment due to high-risk factors. Read here for an analysis of TMDX stock drop and future prospects.

Shares of organ transplant innovator TransMedics Group ( TMDX -1.41%) fell 15.7% through Thursday trading, according to data from S&P Global Market Intelligence. TransMedics was the target of an ...

Euro US Dollar, Gold Spot US Dollar, US Dollar Index Futures, Gold Futures. Read Octa's latest article on Investing.com ...

ASX bank stocks fell on Friday but mining stocks rose as talk of a potential mega merger between Rio Tinto and Glencore ...

TransMedics is facing allegations of fraud, organ trafficking, and unethical practices that have triggered shareholder ...